跳至主要内容
临床试验/NCT02988635
NCT02988635已完成3 期

Evaluation of Effects of Early Palliative Care on Quality of Life of Advanced Cancer Patients. A Multicenter Controlled Randomised Clinical Trial

Azienda Ospedaliero-Universitaria di Parma0 个研究点目标入组 281 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
281
主要终点
Functional Assessment of Cancer Therapy-General (FACT-G) (Quality of life measure)

研究概览

简要总结

This study compares two types of care - Standard Oncology Care (SOC) and SOC with early palliative care (EPC) (started within 8 weeks after diagnosis of advanced disease) to see which is better for improving the quality of life of patients with advanced lung, pancreas, gastric and biliary tract cancer. The study will use FACT-G questionnaire to measure patients' quality of life.

详细描述

The patients will complete a baseline FACT-G questionnaire and then will be randomized to a study group.

Subjects who are randomized to Standard Oncology Care (SOC) will follow up with their treating oncologist. They will consult with the palliative care team at their request or at the request of the treating oncologist or of the family. They will complete FACT-G questionnaire at 12 weeks after enrollment.

Subjects who are randomized to the SOC with Early Palliative Care (EPC) will meet with a palliative care team (basically composed by a palliative care physician and a palliative care specialized nurse) at their next medical oncology or infusion visit. They will meet with the palliative care team at least every three weeks. They will complete FACT-G questionnaire at 12 weeks after enrollment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pathologically confirmed metastatic lung (NSCLC), pancreatic, gastric and biliary tract cancer, diagnosed within the previous 8 weeks; an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2; age ± 18 years; metastatic or locally advanced disease (but not susceptible of loco-regional treatments); eligibility to first-line chemotherapy ± biological agents; life expectancy more than three months; written informed consent provided; FACT-G questionnaire filled in at enrollment, before the randomization.

排除标准

  • Patients already receiving care from the PC service or pretreated with chemotherapy ± biological

结局指标

主要结局

Functional Assessment of Cancer Therapy-General (FACT-G) (Quality of life measure)

时间窗: Change from baseline to 12 weeks

compare change in QOL from baseline to 12 weeks between study arms

次要结局

  • Survival(from date of randomization until date of death or for a minimum of six months)
  • Resource utilization at the end of life (EOL): chemotherapy utilization(From date of randomization until death or for a minimum of six months after enrollment)
  • Resource utilization at the end of life (EOL): hospital admissions(From date of randomization until death or for a minimum of six months after enrollment)
  • Resource utilization at the end of life (EOL): emergency room admissions(From date of randomization until death or for a minimum of six months after enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vittorio Franciosi

M.D.

Azienda Ospedaliero-Universitaria di Parma

相似试验